Induction of immunological tolerance to islet allografts
- 1 February 1996
- journal article
- Published by Elsevier in Cell Transplantation
- Vol. 5 (1) , 49-52
- https://doi.org/10.1016/0963-6897(95)02010-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tolerogenicity of resting and activated B cells.The Journal of Experimental Medicine, 1994
- In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.The Journal of Experimental Medicine, 1993
- Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40Science, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- B Cells Turn Off Virgin But Not Memory T CellsScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.The Journal of Experimental Medicine, 1992
- Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor ratsDiabetes, 1990
- Pancreatic Islet Allograft Prolongation by Donor-Specific Blood Transfusions Treated with Ultraviolet IrradiationScience, 1983
- Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte ConceptAnnual Review of Immunology, 1983